Table 1 Studies using radiation therapy rat model in combination with anticancer therapeutic agents
From: External irradiation models for intracranial 9L glioma studies
Studies | Target | Tumor Cell line | Total dose | Number of fractions | Survival |
|---|---|---|---|---|---|
Roullin VG (6) | HB | C6 | 36 Gy | 9 | Complete response : 8% |
Graf MR (7) | WB | T9 | 15 Gy | 1 | 35 days (median) |
Kimler BF (8) | WB | 9L | 20 Gy | 1 | S |
30 Gy | 5 | S | |||
Kimler BF (9) | WB | 9L | 40-70 Gy | 10-20 | S |
Kimler BF (10) | WB | 9L | 16 Gy | 1 | 38.5 days (mean) |
Kimler BF (11) | WB | 9L | 16 Gy | 1 | S |
24 Gy | 1 | S | |||
32 Gy | 1 | S | |||
40 Gy | 1 | S | |||
Lamproglou I (12) | WB | - | 30 Gy | 10 | - |
Olson JJ (13) | WB | 9L | 30 Gy | 1 | 29.7 days (mean) |